Seeking Alpha

More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown:...

More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown: specialty pharmaceuticals +5% and 8.8% on a constant currency basis; medical devices +4% and +8.3%. Guidance: FY EPS $4.15-$4.19 vs. consensus of $4.17, revenue of $4.74B-$4.85B vs. $5.85B. Q3: EPS of $1.02-$1.04 vs. $1.06, revenue of $1.37B-$1.445B vs. $1.44B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)